Beta-Lactams: Penicillin Family
Antibiotics |
Bacteria |
Notes |
Natural Penicillin (PCN G / PCN V) |
↦ Strep ↦ Staph (non-β-lactamase) ↦ Treponema pallidum (syphilis) |
DOC for Syphilis |
Anti-Staph. Penicillin (Nafcillin / Dicloxacillin) |
↦ Staph. aureus (penicillinase-producing) ↦ Some Strep |
DOC for MSSA infections |
Aminopenicillins (Ampicillin / Amoxicillin) |
↦ Streptococcus spp. ↦ Enterococcus faecalis ↦ Enterobacteriaceae (some) ↦ Listeria monocytogenes |
DOC for susceptible Enterococcus and Listeria infections |
Amoxicillin/clavulanate (Augmentin®) |
↦ Strep + Staph. aureus ↦ E. coli + Klebsiella ↦ H. flu + Moraxella catarrhalis ↦ Anaerobes |
Mixed infections: (GP+GN+anaerobes) such as Diabetic Foot Ulcers |
Ampicillin/sulbactam (Unasyn®) |
Similar to Amoxicillin/clavulanate + broader activity against anaerobes (sulbactam = acinetobacter) |
Mixed infections: (GP+GN+anaerobes) such as Diabetic Foot Ulcers |
Piperacillin/tazobactam (Zosyn®) |
Similar to Amoxicillin/clavulanate + Pseudomonas aeruginosa |
Same as above PLUS Pseudomonas |
Mechanism of Action:
1. Binds to Penicillin Binding Proteins (PBPs) located on the bacterial cell wall
2. PBPs catalyze peptidoglycan synthesize which interferes with bacterial cell wall
construction → Bacteria lysis and death
3. Number and type of PBPs vary between different bacteria
4. Time Dependent killing
Beta-Lactam: Cephalosporin
Antibiotics |
Bacteria |
Drug-of-Choice |
1st Generation (Cefazolin / Cephalexin) |
↦ Streptococcus + Staph (including some MSSA) ↦ PEK: Proteus, E. coli, Klebsiella pneumoniae |
SSTI Surgical prophylaxis |
2nd Generation (Cefoxitin / Cefotetan) |
Enhanced activity against gram (–) bacteria including ↦ Some anaerobes (B. fragilis) ↦ Streptococcus + Staph (including some MSSA) ↦ H. flu + Enterobacter aerogenes |
Intra-abdominal infections Prophylaxis pre-surgery |
2nd Generation (Cefuroxime / Cefaclor) |
↦ Streptococcus + Staph (including some MSSA) ↦ H. influenzae + M. catarrhalis + Neisseria (some) ↦ E. coli + K. pneumoniae |
URT infections |
3rd Generation (Ceftriaxone / Ceftazidime) |
Broad spectrum including ↦ Many gram (–) bacteria ↦ Streptococcus + Staph (including some MSSA) ↦ H. influenzae + M. catarrhalis + Neisseria ↦ (Ceftazidime = Pseudomonas) |
Meningitis Gonorrhea (Ceftriaxone) |
3rd Generation (Cefixime / Cefpodoxime / Cefdinir) |
↦ Streptococcus + Staph (including some MSSA) ↦ H. influenzae + M. catarrhalis ↦ Enterobacteriaceae: E. coli + K. pneumoniae |
Community-acquired infections |
4th Generation (Cefepime) |
Broad-spectrum activity including ↦ Pseudomonas aeruginosa ↦ Many gram (–) bacteria ↦ Streptococcus + Staph (including some MSSA) |
HAP Febrile neutropenia |
5th Generation/Anti-MRSA (Ceftaroline) |
Broad spectrum including ↦ MRSA + Streptococcus spp ↦ Some gram (–) bacteria
|
SSTI CAP |
Very safe antibiotics
Less frequent dosing compared to PCNs
Cephalosporins are intrinsically resistant to ALL Enterococci and Listeria species
All agents are metabolized by the kidneys EXCEPT Ceftriaxone (hepatic metabolism; hepatic/renal excretion)
Beta-Lactam: Carbapenems Family
Antibiotics |
Bacteria |
Drug-of-Choice |
Imipenem/Cilastatin Meropenem |
↦ Gram (+) – Not Enterococcus faecium ↦ Gram (–) & Pseudomonas ↦ Anaerobes |
↦ DOC for Enterobacter, Serratia and ESBL ↦ Severe hospital-acquired infections ↦ Complicated infections |
Ertapenem |
↦ Gram (+) cocci ↦ Many Gram (–) rods ↦ Anaerobes ↦ Less active against Pseudomonas and Acinetobacter |
↦ CAP ↦ Complicated intra-abdominal infections |
Meropenem/Vaborbactam Imipenem/Cilastatin/Relebactam |
Same as ABOVE PLUS ↦ Resistant gram (–) such as CRE |
↦ Complicated UTIs ↦ HAP/VAP |
Carbapenems are very broad spectrum (similar in activity to Piperacillin/Tazobactam) and usually used for hospital acquired/serious/resistant infections
1) Usually used for hospital acquired organisms that have developed resistance to other cell wall inhibitors (aka, Extended Spectrum Beta Lactamase Producers)
2) Reserve to use for resistant infections
Beta-Lactam: Monobactam Family
Antibiotics |
Bacteria |
Drug-of-Choice |
Aztreonam |
↦ ONLY Gram (–) including Neisseria, H. flu, Enterobacteriaceae, and Pseudomonas ↦ No anaerobes |
↦ Alternative agent for GRAM (-) infections in those with PCN allergies ↦ Mainly for hospital related infections, critically ill, or sepsis. |
Narrower spectrum of activity compared to other beta-lactams
1) ONLY Gram (-) activity, no anaerobes
2) No cross reactivity with other beta-lactams
3) Can be used safely in those with PCN allergies
Vancomycin and Glycopeptides
Antibiotics |
Bacteria |
Drug-of-Choice |
Vancomycin |
↦ ONLY gram (+) including MRSA and sensitive Enterococci ↦ PO for C. diff |
↦ For either resistant infections or beta-Lactam allergies ↦ Must monitor levels: AUC/MIC ratio ↦ PO can be used for C. diff infections |
Televancin |
↦ Only Gram (+) including MRSA and sensitive Enterococci ↦ DOES NOT cover VRE |
↦ Potentially can be used for Vancomycin-resistant S. aureus (VRSA) ↦ Increase mortality when used for HAP with renal impairment ↦ Contraindicated in pregnancy |
Dalbavancin |
↦ Only Gram (+) including MRSA and sensitive Enterococci |
↦ Skin/Soft Tissue Infections (SSTIs) |
Oritavancin |
↦ Only Gram (+) including MRSA and sensitive Enterococci ↦ COVERS VRE |
↦ Skin/Soft Tissue Infections (SSTIs) |
1) Only has Gram (+) Activity
2) Mainly used to cover either Beta-Lactam Resistant Infections (MRSA, PCN resistant Strep pneumo, Amp resistant Enterococcus) OR
3) Alternative for Gram (+) infections in those with Beta-Lactam allergies
Daptomycin vs. Polymyxin (Colistin)
Daptomycin |
ONLY Gram (+) and for resistance infection including ↦ MRSA/MSSA/VISA/VRSA ↦ Enterococci (include VRE) ↦ Streptococcus |
↦ Alternative agent for GRAM (-) infections in those with PCN allergies ↦ Mainly for hospital related infections, critically ill, or sepsis. |
Colistin |
Resistant Gram (–) infections including Pseudomonas |
For resistant Gram (-) infections |
Daptomycin: Cannot use for pneumonia due to inactivation by lung surfactant
Polymyxin: Old class of drugs that have gained new popularity for resistant Gram (-) infections
Macrolide Family
Antibiotics |
Bacteria |
Drug-of-Choice |
Erythromycin |
↦ Gram (+) ↦ Gram (–) ↦ Atypical organisms ↦ Mycobacterium sp. |
↦ CAP / Sinusitis / Otitis Media ↦ Atypical infections ↦ Lyme’s disease |
Clarithromycin |
↦ Gram (+) ↦ Gram (–) ↦ Atypical organisms ↦ Mycobacterium sp. ↦ BETTER H.flu coverage |
↦ CAP / Sinusitis / Otitis Media ↦ Atypical infections ↦ Lyme’s disease ↦ Mycobacterial infections |
Azithromycin |
↦ Gram (+), but less activity ↦ Gram (–) ↦ Atypical organisms ↦ Mycobacterium sp. ↦ BETTER H.flu coverage |
↦ CAP / Sinusitis / Otitis Media ↦ Atypical infections ↦ Lyme’s disease ↦ Mycobacterial infections ↦ Frequently used as one time dose (1 g) for Chlamydia treatment. |
Can be used safely with PCN allergies
Macrolide Family
Antibiotics |
Bacteria |
Drug-of-Choice |
Erythromycin |
↦ Gram (+) ↦ Gram (–) ↦ Atypical organisms ↦ Mycobacterium sp. |
↦ CAP / Sinusitis / Otitis Media ↦ Atypical infections ↦ Lyme’s disease |
Clarithromycin |
↦ Gram (+) ↦ Gram (–) ↦ Atypical organisms ↦ Mycobacterium sp. ↦ BETTER H.flu coverage |
↦ CAP / Sinusitis / Otitis Media ↦ Atypical infections ↦ Lyme’s disease ↦ Mycobacterial infections |
Azithromycin |
↦ Gram (+), but less activity ↦ Gram (–) ↦ Atypical organisms ↦ Mycobacterium sp. ↦ BETTER H.flu coverage |
↦ CAP / Sinusitis / Otitis Media ↦ Atypical infections ↦ Lyme’s disease ↦ Mycobacterial infections ↦ Frequently used as one time dose (1 g) for Chlamydia treatment. |
Can be used safely with PCN allergies
Tetracyclines Family
Antibiotics |
Bacteria |
Drug-of-Choice |
Tetracycline Doxycycline Minocycline |
Gram (+) ↦ MRSA & Streptococcus Some Gram (-) ↦ Atypical infections ↦ Chlamydia/gonorrhea ↦ Tick borne disease |
↦ Tick or spider bites ↦ Lyme’s Disease ↦ CAP ↦ SSTI, esp. MRSA ↦ Atypical respiratory infections |
Tigecycline |
Gram (+) ↦ MRSA & Streptococcus ↦ VRE Some Gram (-) Some Anaerobe Atypical infections |
↦ Chlamydia/gonorrhea ↦ Tick borne disease ↦ Complicated IAI ↦ Skin/soft tissue infections ↦ MRSA/VRE infections |
Eravacycline Omadacycline |
Gram (+) ↦ MRSA & Streptococcus ↦ VRE Some Gram (-) Some Anaerobe Atypical infections |
↦ SSTI ↦ CAP ↦ Complicated intra-abdominal infection (IAI) |
Spectrum of Activity: Very Broad- Gram-positive (including MRSA), Gram-negative, Rickettsia and other Tick borne diseases, Chlamydia, some protozoa
Omadacycline, Eravacycline, and Tigecycline also cover enterococci (including VRE)
Aminoglycosides Family
Antibiotics |
Bacteria |
Drug-of-Choice |
Tobramycin Gentamicin Amikacin
|
↦ Gram (-) + Pseudomonas ↦ Gram (+) → Synergy dosing for Enterococcal infective Endocarditis ↦ Amikacin only covers mycobacterium sp. |
↦ Resistant G- infections ↦ Synergy with beta-lactam/glycopeptide in enterococcal endocarditis |
Plazomicin |
↦ Gram (-) + Pseudomonas ↦ Gram (+) → Synergy w/ with a beta-lactam/glycopeptide for Enterococcal infective Endocarditis ↦ CRE |
↦ Resistant G- infections, including UTI ↦ Plague |
Spectrum of Activity
1) Mostly Gram (-), mycobacterium, synergy for Gram + infections when used with a beta-lactam or glycopeptide
2) Most frequently used now for resistant gram – infections or in combination with an extended spectrum beta-lactam (additional coverage for resistant Gram (-) infections) in serious infections such as neutropenic fever or sepsis
Oxazolidinones Family
Antibiotics |
Bacteria |
Drug-of-Choice |
Linezolid |
ALL Gram (+) organisms ↦ MsSA/MRSA/VISA/VRSA ↦ Enterococci (VRE) ↦ Streptococcus Some Atypicals |
↦ SSTIs ↦ Suspected MRSA / VRE infections |
Tedizolid |
Same as ABOVE PLUS ↦ Gram (-) anaerobes |
↦ SSTIs |
Spectrum of Activity: Gram + (MRSA + VRE) , some atypical organisms, Mycobacterium sp., and Nocardia
Others Protein Synthesis Inhibitors
Antibiotics |
Bacteria |
Drug-of-Choice |
Lincosamide (Clindamycin) |
↦ Gram (+) → MSSA + some MRSA ↦ Anaerobes (esp. mouth) including Peptostreptococcus, Bacteroides, Prevotella, and Fusobacterium Strep + Staph infections |
↦ DOC for Pelvic Inflammatory Disease (PID) ↦ Used in combo with PCN for toxin producing strains for Clostridium perfringens and S. pyogenes; commonly occurs with necrotizing fasciitis ↦ Alternative for G+ infections with PCN allergy ↦ Dental infections, IAI, and Pelvic infections ↦ Can be used topically for acne |
Pleuromutilin (Lefamulin) |
↦ Gram (+) organisms ↦ Gram (-) organisms (limited) ↦ Atypicals |
↦ CAP |
Streptogramins (Quinupristin/Dalfopristin) |
↦ Gram (+) organisms ↦ MSSA/MRSA ↦ Strep ↦ Enterococcus (VRE) |
Fluoroquinolones Family
Antibiotics |
Bacteria |
Drug-of-Choice |
Ciprofloxacin |
↦ Mostly Gram (+) ↦ Some Gram (–) → Pseudomonas, but not as good as other agents ↦ Atypical organisms |
↦ UTIs ↦ GNR bacteremia, bone/joint infections, hospital related infections ↦ Alternative for GNR infections in those w/ beta-lactam allergies ↦ DON'T use for respiratory infections |
Levofloxacin |
↦ Mostly Gram (+) ↦ Some Gram (–) → Pseudomonas, but not as good as other agents ↦ Atypical organisms |
↦ UTIs / CAP / SSTIs / Sinusitis ↦ GNR bacteremia, bone/joint infections, and hospital related infections ↦ Alternative for GNR infections in those w/ beta-lactam allergies ↦ Alternative for mycobacterial infections |
Delafloxacin |
↦ Gram (+): MRSA ↦ Some Gram (-) →Pseudomonas ↦ Atypical organisms |
↦ SSTIs |
Moxifloxacin |
↦ Mostly Gram (+) ↦ Some Gram (-) → Not as good as other agents ↦ Atypical organisms ↦ Anaerobic coverage |
↦ CAP / SSTIs |
Spectrum of Activity: Varies by Agent, but broad spectrum (Gram +, Gram -, Atypical)
1) Respiratory FQ: Levofloxacin, Delafloxacin, Moxifloxacin ("Let's Do Meditation")
2) Pseudomonas: Levofloxacin, Ciprofloxacin, Delafloxacin ("Let's Cancer Die")
3) Anaerobes: Moxifloxacin
4) MRSA: Delafloxacin ("MR Del is like Modella beer")
Rifamycins Family
Antibiotics |
Bacteria |
Drug-of-Choice |
Rifampin |
↦ Mycobacterium species ↦ Gram (+) → MRSA |
↦ Never use as solo agent |
Rifabutin |
↦ Mycobacterium species
|
↦ Less DDIs → Preferred drug for patients on antiretrovirals |
Rifapentine |
↦ Mycobacterium species |
Rifaximin |
↦ Gram (+) ↦ Gram (-) → Enterobacteriaceae |
↦ Only active in GI tract ↦ Can’t use to treat systemic infections |
Spectrum of Activity
• Rifampin, Rifabutin, Rifapentine → Mycobacterium species
• Rifampin: Gram + (MRSA); never use ALONE
• Rifaximin: Gram +, Gram – such as Enterobacteriaceae; ONLY active in the GI tract
Miscellaneous Nucleic Acid Synthesis Inhibitors
Antibiotics |
Bacteria |
Drug-of-Choice |
Metronidazole |
↦ Gram (+) ↦ Gram (–) ↦ Anaerobes ↦ Protozoa |
↦ In combo with other agents to cover anaerobes ↦ Bacterial vaginosis ↦ H. pylori treatment ↦ Crohn’s disease ↦ Giardia infections |
Nitrofurantoin Fosfomycin |
↦ Gram (+) → Staph ↦ Gram (–) → Enterococcus (VRE) + GNR ↦ Fosfomycin covers ESBL |
↦ Lower UTIs |
Metronidazole: Gram – and + anaerobes and protozoa
Nitrofurantoin: Staphylococcus, Enterococcus (including VRE) and GNRs (not pseudomonas)
Fosfomycin: Staphylococcus, Enterococcus (including VRE) and GNRs including many resistant one such as ESBL
Sulfonamides Family
Antibiotics |
Bacteria |
Drug-of-Choice |
Sulfonamides (Sulfamethoxazole/trimethoprim) |
↦ Some streptococcus sp. ↦ Staphylococcus (MRSA) ↦ Enterobacteriaceae, Listeria, and Nocardia ↦ Pneumocystis jiroveci |
↦ DOC for Nocardia and Pneumocystis jiroveci ↦ UTIs / SSTIs (MRSA) ↦ Treatment of/prevention of infection in immunocompromised |
|
Created By
Metadata
Comments
No comments yet. Add yours below!
Add a Comment
Related Cheat Sheets
More Cheat Sheets by chautommy93